NCT07584343

Brief Summary

In this observational study embedded within a randomized controlled trial, the investigators aim to characterize the activation patterns of the tibialis anterior and medial gastrocnemius muscles in the more rigid leg of patients with Parkinson's disease when performing walking tasks under dual cognitive-task conditions, which are known to increase the risk of falls in this population. To this end, a control group without neurological disorders and with comparable sociodemographic characteristics will also be assessed. The study seeks to determine whether significant changes occur in forward and backward gait as a function of the dual-task condition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 15, 2026

Completed
15 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 30, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 13, 2026

Completed
Last Updated

May 13, 2026

Status Verified

May 1, 2026

Enrollment Period

15 days

First QC Date

April 30, 2026

Last Update Submit

May 7, 2026

Conditions

Keywords

Parkinson DiseaseGait Disorders, NeurologicDual-Task TestsMuscle ContractionWearable Electronic Devices

Outcome Measures

Primary Outcomes (1)

  • %MIVC

    It was calculated by expressing the Root Mean Square (RMS) value for each condition as a percentage of the Maximal Voluntary Contraction (MVC) obtained during the isometric test. This approach ensures accurate quantification of neuromuscular effort, which is essential to minimize bias arising from anatomical and physiological differences between subjects.

    Baseline (Day 1)

Secondary Outcomes (2)

  • CVM

    Baseline (Day 1)

  • Ratio (GM/TA)

    Baseline (Day 1)

Study Arms (2)

Parkinson Desease

Patients with Parkinson's disease recruited from the Parkinson's Association of Seville

Healthy Subjects

Patients with similar sociodemographic characteristics without neurological disorders

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with Parkinson's disease and mild cognitive and gait functional impairment recruited from the Parkinson's Association of Seville.

You may qualify if:

  • Ability to walk independently for at least 5 meters, both forward and backward, without the need for assistive devices or assistance from another person.
  • Diagnosis of idiopathic Parkinson's disease made by a neurologist at Hospital Virgen Macarena.
  • Hoehn and Yahr stage I-III.
  • Being in the "ON" phase of antiparkinsonian medication during the assessment (approximately one hour after intake, when the pharmacokinetic curve of levodopa reaches its peak).

You may not qualify if:

  • Presence of symptomatic musculoskeletal disorders affecting the lower limbs (LL) (relevant orthopedic surgery or leg length discrepancy \> 1 cm), or other neurological conditions (stroke, neuropathies, etc.) that independently affect gait.
  • Balance disorders due to other causes (vestibulopathy, severe orthostatic hypotension, etc.).
  • Decompensated systemic diseases (cardiac disease, COPD, uncontrolled diabetes mellitus, etc.).
  • Uncorrected visual impairments that may affect gait performance.
  • Previous treatment with deep brain stimulation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sevilla, España

Seville, Sevilla, 41015, Spain

Location

Related Links

MeSH Terms

Conditions

Parkinson DiseaseGait Disorders, Neurologic

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physiotherapist

Study Record Dates

First Submitted

April 30, 2026

First Posted

May 13, 2026

Study Start

March 15, 2026

Primary Completion

March 30, 2026

Study Completion

March 30, 2026

Last Updated

May 13, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations